239 related articles for article (PubMed ID: 25666625)
1. Epidermal growth factor receptor (EGFR) signaling requires a specific endoplasmic reticulum thioredoxin for the post-translational control of receptor presentation to the cell surface.
Dong A; Wodziak D; Lowe AW
J Biol Chem; 2015 Mar; 290(13):8016-27. PubMed ID: 25666625
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration.
Wodziak D; Dong A; Basin MF; Lowe AW
PLoS One; 2016; 11(10):e0164968. PubMed ID: 27764193
[TBL] [Abstract][Full Text] [Related]
3. AGR2 gene function requires a unique endoplasmic reticulum localization motif.
Gupta A; Dong A; Lowe AW
J Biol Chem; 2012 Feb; 287(7):4773-82. PubMed ID: 22184114
[TBL] [Abstract][Full Text] [Related]
4. The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation.
Dong A; Gupta A; Pai RK; Tun M; Lowe AW
J Biol Chem; 2011 May; 286(20):18301-10. PubMed ID: 21454516
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the polybasic juxtamembrane sequence of both plasma membrane- and endoplasmic reticulum-localized epidermal growth factor receptors confer ligand-independent cell transformation.
Bryant KL; Antonyak MA; Cerione RA; Baird B; Holowka D
J Biol Chem; 2013 Nov; 288(48):34930-42. PubMed ID: 24142702
[TBL] [Abstract][Full Text] [Related]
6. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
Arteaga CL; Ramsey TT; Shawver LK; Guyer CA
J Biol Chem; 1997 Sep; 272(37):23247-54. PubMed ID: 9287333
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
Lee FT; Mountain AJ; Kelly MP; Hall C; Rigopoulos A; Johns TG; Smyth FE; Brechbiel MW; Nice EC; Burgess AW; Scott AM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7080s-7086s. PubMed ID: 16203806
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers.
Luu TT; Bach DH; Kim D; Hu R; Park HJ; Lee SK
Anticancer Res; 2020 Apr; 40(4):1855-1866. PubMed ID: 32234873
[TBL] [Abstract][Full Text] [Related]
9. IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells.
Itoh T; Hatano R; Horimoto Y; Yamada T; Song D; Otsuka H; Shirakawa Y; Mastuoka S; Iwao N; Aune TM; Dang NH; Kaneko Y; Okumura K; Morimoto C; Ohnuma K
Cell Death Dis; 2021 May; 12(6):520. PubMed ID: 34021125
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet irradiation-induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes.
Xu Y; Shao Y; Zhou J; Voorhees JJ; Fisher GJ
J Cell Biochem; 2009 Aug; 107(5):873-80. PubMed ID: 19415674
[TBL] [Abstract][Full Text] [Related]
11. AGR2, an endoplasmic reticulum protein, is secreted into the gastrointestinal mucus.
Bergström JH; Berg KA; Rodríguez-Piñeiro AM; Stecher B; Johansson ME; Hansson GC
PLoS One; 2014; 9(8):e104186. PubMed ID: 25111734
[TBL] [Abstract][Full Text] [Related]
12. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
Baba Y; Maeda T; Suzuki A; Takada S; Fujii M; Kato Y
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134774
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
Peace BE; Hill KJ; Degen SJ; Waltz SE
Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
[TBL] [Abstract][Full Text] [Related]
14. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy.
Dowlati A; Nethery D; Kern JA
Mol Cancer Ther; 2004 Apr; 3(4):459-63. PubMed ID: 15078989
[TBL] [Abstract][Full Text] [Related]
16. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
[TBL] [Abstract][Full Text] [Related]
17. Integrin α5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-Glycosylation.
Hang Q; Isaji T; Hou S; Im S; Fukuda T; Gu J
J Biol Chem; 2015 Dec; 290(49):29345-60. PubMed ID: 26483551
[TBL] [Abstract][Full Text] [Related]
18. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
19. The anterior gradient-2 interactome.
Delom F; Mohtar MA; Hupp T; Fessart D
Am J Physiol Cell Physiol; 2020 Jan; 318(1):C40-C47. PubMed ID: 31644305
[TBL] [Abstract][Full Text] [Related]
20. Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues.
Narumi S; Miki Y; Hata S; Ebina M; Saito M; Mori K; Kobayashi M; Suzuki T; Iwabuchi E; Sato I; Maemondo M; Endo C; Inoue A; Kondo T; Yamada-Okabe H; Ichinose M; Sasano H
Int J Biol Markers; 2015 May; 30(2):e234-42. PubMed ID: 25634032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
